FDA Eliminates REMS Program for Certain Autologous CAR T-Cell Therapies
July 02, 2025
July 02, 2025
NORTH HOLLYWOOD, California, July 2 -- The International Myeloma Foundation issued the following news:
* * *
FDA Eliminates REMS Program for Certain Autologous CAR T-cell Therapies
FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) Program for Certain Autologous CAR T-cell Therapies
*
According to this press release from the U.S. Food and Drug Administration, "The U.S. Food and Drug Administration announced today . . .
* * *
FDA Eliminates REMS Program for Certain Autologous CAR T-cell Therapies
FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) Program for Certain Autologous CAR T-cell Therapies
*
According to this press release from the U.S. Food and Drug Administration, "The U.S. Food and Drug Administration announced today . . .